Ocular therapy using alpha-2 adrenergic receptor agonists having enhanced anterior clearance rates

Details for Australian Patent Application No. 2006244083 (hide)

Owner Allergan Inc.

Inventors Burke, James A.; Hughes, Patric M.; Chang-Lin, Joan-En

Agent Davies Collison Cave

Pub. Number AU-A-2006244083

PCT Pub. Number WO2006/122165

Priority 60/679,771 10.05.05 US

Filing date 9 May 2006

Wipo publication date 16 November 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/122165 Priority application(s): WO2006/122165

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244085-Medication safety system featuring a multiplexed RFID interrogator panel

2006244081-Capability assessment of a training program